PARK7 and Parkinson disease: As expected, pretreatment of DJ-1-deficient cells with ZAP resulted in a significant increase in the number of viable mitochondria compared to vehicle-treated cells (Fig. 4), supporting the therapeutic potential of ZAP as a means to ameliorate PD-associated mitochondrial dysfunction.